Session Title: Quick Fire Free Paper 5
Session Date/Time: Sunday 14/09/2014 | 11:00-13:00
Paper Time: 11:30
Venue: Boulevard B
First Author: : A.Khattab EGYPT
Co Author(s): : M. Torkey
to evaluate triple therapy, with intravitreal bevacizumab (IVB), posterior sub-Tenon’s (SBT) triamcinolone, and panretinal photocoagulation (PRP), in ED patients with vitreous hemorrhage and its associated vasculitis, neovascularization, and macular edema.
Al Bahar eye center, Ibn Sinai hospital of Kuwait Ministry of Health in the period from August 2010 to December 2010.
prospective, interventional case series. This study included 20 eyes of 20 patients with vitreous hemorrhage because of ED. Preoperative evaluation included patient age, sex, race, medical history, medications, complete ophthalmological examination, and diagnostic laboratory evaluation. All eyes were treated with IVB, posterior SBT triamcinolone, and PRP. The follow-up period was up to 6 months. The main outcome measures were visual acuity, intraocular pressure changes, and recurrence of vitreous hemorrhage
A statistically significant improvement in visual acuity was observed at 1 week and 1, 3, and 6 months postoperatively. There was no statistically significant change in intraocular pressure at any of the postoperative follow-up intervals. There was no intraoperative or postoperative complication. None of the patients included had any recurrence during the follow-up.
The triple therapy with IVB, posterior SBT triamcinolone, and PRP seems to be effective in the treatment of ED patients with dense vitreous hemorrhage and its associated vasculitis, neovascularization, and macular edema.